2025 annual financial data
Summit Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -1,094,374,000 GBP and net income was -1,079,586,000 GBP.
Operating cash flow was -239,665,728 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -1,094,374,000 GBP
- Net income
- -1,079,586,000 GBP
- Operating cash flow
- -239,665,728 GBP